Clinical Research Papers:

Comparing children and adults with medulloblastoma: a SEER based analysis

Qian Li, Zhenguo Dai, Yuze Cao and Lihua Wang _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:30189-30198. https://doi.org/10.18632/oncotarget.23773

Metrics: PDF 1740 views  |   HTML 2264 views  |   ?  


Qian Li1, Zhenguo Dai2, Yuze Cao1 and Lihua Wang1

1Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, Heilongjiang, China

2Department of Cardiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, Heilongjiang, China

Correspondence to:

Lihua Wang, email: [email protected]

Keywords: medulloblastoma; SEER; survival; treatment; prognostic factors

Received: June 08, 2017     Accepted: December 26, 2017     Published: July 10, 2018


Medulloblastoma (MB) is a brain malignancy, which commonly occurs in children, but is rare in adults. The Surveillance, Epidemiology, and End Results (SEER) database was used to compare survival, clinical features, and prognostic factors of children and adults with MB from 1992 to 2013. Overall survival estimates were compared using the Kaplan–Meier method, and Cox Proportion Hazard Regression modeling was used to evaluate prognostic variables. We identified 616 children (63.8%) and 349 adults (36.2%) with diagnosis of MB. The estimated survival rates for children diagnosed with MB for 2, 5, and 10 years were 85.6%, 75.5%, and 67.9%, respectively; the corresponding estimates for adults were 84.9%, 74.2%, and 67.3%. Radiotherapy was the only identical prognostic factor observed in the two groups. Children MB patients were more likely to experience distal metastases that was associated with increased hazard of mortality, and be diagnosed after 2003. Among adult MB patients, gross total resection (GTR) was a favorable prognostic factor, while large cell/anaplastic (LC/A) histology was correlated with decreased survival. Our analysis highlighted that both groups had similar overall survival time, but the prognostic factors were not comparable, except radiotherapy which was associated with better survival.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23773